A study presented ACAAI Annual Scientific Meeting shows different levels of health literacy among teens and caregivers regarding asthma.
GlaxoSmithKline is developing a new treatment for severe asthma and is filing for US and European applications for the injectable mepolizumab.
A new study based on EU adverse drug reaction reports documents that children’s use of asthma medications may result in severe adverse drug reactions.
A new Tel Aviv University study shows that boosting vitamin D levels can help manage asthma attacks.
A study that compared the care delivered to patients in hospital emergency departments (EDs) for acute asthma attacks with data gathered more than 15 years earlier reveals inconsistencies in how well hospitals are meeting nationally established treatment guidelines.
UCSF researchers have identified a novel factor that puts the brakes on airway smooth-muscle contraction relevant to asthma.
The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase IIb study evaluating benralizumab in patients with severe, uncontrolled asthma and elevated levels of eosinophils.
Fractional exhaled nitric oxide measurement is a safe, reliable diagnostic of airway inflammation for asthmatics, but the technology is typically underused in clinical settings.
UTHealth will use a four-year, $1.3 million grant from the CDC and NIOSH to study how the risk of asthma has changed for healthcare workers in Texas over the last 10 years.
An article suggests it is more probable that childhood obesity contributes to asthma, although the connection is complex and has many factors.